Our mission to bridge nature and health
We understand that whole-body health and wellness is tied to the complex ecosystem of microorganisms that is the microbiome, and that addressing healthy microbiome balance will transform people’s lives from the inside.
Our mission is simple: We want to empower people with products and nutritional information that help them live healthy, well-balanced lives. To that end, we aim to create products that have power and quality with the accessibility of a probiotic.
More than a microbiome scientist, our CEO is a mum.
Colleen Cutcliffe has an impressive background leading and managing biology teams. She’s a scientist with a Ph.D. in Biochemistry and Microbiology from Johns Hopkins University and has held senior positions at bioscience and pharmaceutical firms. She’s also a mum, not to mention our CEO.
Colleen and her two co-founders, John and Jim, saw an opportunity to apply next-generation DNA sequencing technologies and microbiological assays to the emerging microbiome science space. Using these data, they could create metabolic maps of the microbiome and use systems biology to make novel insights into the microbiome. This scientific trio was uniquely positioned to bring new products to the world.
It was her role as a mum, however, that inspired her to team up with her two former colleagues and create Pendulum. Colleen’s first daughter was born eight weeks prematurely. That meant instead of heading home that day with mum and dad, she was whisked away to the NICU for four weeks, receiving multiple doses of antibiotics as a precautionary measure due to her fragile state.
As she got older, Colleen began to notice distinct differences in Annabella’s metabolism compared to the rest of their family. She had to deal with food sensitivities in elementary school.
This led Colleen, John and Jim on their journey to find a solution to help support her daughter and many others who may need to support a healthy, balanced microbiome. And, this set the stage for the vision of the company to create a new generation of natural products that support the microbiome.
After nearly a decade of research, Pendulum was born and remains a central part of Colleen and Annabella’s wellness.
Colleen Cutcliffe
CEO AND CO-FOUNDERColleen Cutcliffe is the Chief Executive Officer and co-founder of Pendulum. She has more than 15 years of experience leading and managing biology teams in academia, pharmaceuticals, and biotechnology. Prior to starting Pendulum, Colleen was the senior manager of biology at Pacific Biosciences and a scientist at Elan Pharmaceuticals. Colleen completed her postdoctoral studies at Northwestern’s Children’s Memorial Hospital. Colleen received her Ph.D. in Biochemistry and Molecular Biology from John Hopkins University and her B.A. in Biochemistry from Wellesley College.
“I am excited to be at Pendulum working towards unlocking the promise of the microbiome and building products to improve the health and lives of millions of people. Leading a team of world-class experts in lab science, manufacturing, finance and commercialization who work together fantastically makes my job easy.”
Jim Bullard
CO-FOUNDERJim Bullard is Chief Technology Officer and co-founder of Pendulum. Prior, Jim served as a senior staff scientist at Pacific Biosciences. Prior to co-founding Pendulum, Jim completed his Ph.D. in Biostatistics at the University of California, Berkeley and his B.A. in Computing & Information Systems at Northwestern University. He has a passion for experimental design, programming languages, and taking long walks with his dog.
“I feel fortunate to be working with smart, motivated people on interesting problems. Building products that help people is incredibly motivating.”
John Eid
CSO AND CO-FOUNDERJohn Eid is the Chief Science Officer and co-founder of Pendulum. John has led technology development teams for nearly two decades in diverse areas that include advanced microscopy, single molecular detection and analyses, automated data acquisition systems, biophysical systems modeling, and genome sequencing applications. Prior to co-founding Pendulum, John was a principal scientist at Pacific Biosciences. John completed his postdoctoral research at the Roland Institute at Harvard University, received his Ph.D. in Biophysics and Computational Biology at the University of Illinois, Urbana Champaign and his B.S. in Applied and Engineering Physics from Cornell University.
“It is exciting to have a front row seat on the evolution of the microbiome field from a purely academic endeavor into a field that is actually helping people in the here and now.”
Adam Perlman
CHIEF MEDICAL OFFICERDr. Perlman is board-certified in Internal Medicine and specializes in both integrative and functional medicine. With more than 25 years of clinical, entrepreneurial, and leadership experience, he most recently served as the Director of Integrative Health and Wellbeing at the Mayo Clinic. Prior to that, he served as the Associate Vice President for Health and Wellness for the Duke University Health System. Dr. Perlman received his BA from Tufts University, his MD from the Boston University School of Medicine, and his MPH from the Boston University School of Public Health.
"It is critical to educate people on how a targeted approach to a healthy gut microbiome can positively affect overall health and wellbeing to help them improve vitality and live their best lives."
We’re honored to serve alongside our prestigious board members.
Medical Advisory Board
ADAM D’AUGELLI
PARTNER
TRUE VENTURES
COLLEEN CUTCLIFFE
CEO
PENDULUM THERAPEUTICS
CRAIG SHERMAN, GENERAL PARTNER
MERITECH CAPITAL
HEATHER MASON
FMR. SVP
ABBOTT NUTRITIONFMR. SVP
ABBOTT DIAGNOSTICSHUGH MARTIN
CEO
LACUNA TECHNOLOGIES SENSITY BIOSYSTEMS (ACQ VERIZON) PACIFIC BIOSCIENCES (IPO) ONI SYSTEMS (IPO)
JOHN EID
CSO
PENDULUM THERAPEUTICS
PETER BARTON HUTT, SENIOR COUNSEL
SENIOR COUNSEL
COVINGTON & BURLINGFMR. GENERAL COUNSEL
FDAROELOF BOTHA
SEED & EARLY, GROWTH PARTNER
SEQUOIA CAPITAL
Medical Advisory Board
ANNE PETERS, MD
DIRECTOR, CLINICAL DIABETES
UNIVERSITY OF SOUTHERN CALIFORNIA PRIVATE PRACTICE
CAROL WYSHAM, MD
PROFESSOR
UNIVERSITY OF WASHINGTONPRACTITIONER
ROCKWOOD MULTICARE CENTER FOR DIABETESDAVIDA KRUEGER, NP
NURSE PRACTITIONER
HENRY FORD HEALTH SYSTEMCHAIR
AMERICAN DIABETES ASSOCIATION (ADA) RESEARCH FOUNDATIONEMERAN MAYER, MD
DIRECTOR, OPPENHEIMER CENTER FOR NEUROBIOLOGY OF STRESS AND RESILIENCE
PROFESSOR, DEPARTMENT OF MEDICINE
UCLAJAY PASRICHA, MD
CHIEF OF MEDICINE
MAYO CLINIC
JOHN BUSE, MD
CHAIR, DIVISION OF ENDOCRINOLOGY
UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE
PURNA KASHYAP, MBBS
ASSOCIATE PROFESSOR, MEDICINE
MAYO CLINIC
ROBERT RATNER, MD
CHIEF MEDICAL OFFICER
VIRTA HEALTHFMR CHIEF SCIENTIFIC & MEDICAL OFFICER
AMERICAN DIABETES ASSOCIATIONScientific Advisory Board
ALFRED SPORMANN, PH.D.
PROFESSOR, CIVIL AND ENVIRONMENTAL ENGINEERING
STANFORD UNIVERSITY
CHRISTOPHER MASON, PH.D.
PROFESSOR
WEILL CORNELL MEDICINEDIRECTOR OF EMERGING GENOME TECHNOLOGIES
TEMPUS LABS, INC.DIETRICH STEPHAN, PH.D.
CEO
NEUBASE THERAPEUTICSCHAIR, DEPARTMENT OF HUMAN GENETICS
UNIVERSITY OF PITTSBURGHERIC SCHADT, PH.D.
FOUNDER & CEO
SEMA4DEAN FOR PRECISION MEDICINE
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAIPETER TURNBAUGH, PH.D.
ASSISTANT PROFESSOR, DEPARTMENT OF MICROBIOLOGY AND IMMUNOLOGY
UCSF